StonvexLoading…
StonvexStonvexStonvexCore line items from FND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-26 | Annual 2025 2025-12-25 | Q3 2025 2025-09-25 | Q2 2025 2025-06-26 |
|---|---|---|---|---|
Revenue | $1.15B | $4.68B | $3.55B | $2.37B |
Operating Income | $52.40M | $270.07M | $218.14M | $146.12M |
Net Income | $39.71M | $208.65M | $169.32M | $63.18M |
EPS (Diluted) | $0.37 | $1.92 | $1.56 | $1.03 |
Total Assets | $5.58B | $5.47B | $5.52B | $5.41B |
Total Liabilities | $3.12B | $3.06B | $3.16B | $3.12B |
Cash & Equivalents | $293.63M | $249.30M | $204.48M | $176.88M |
Free Cash Flow OCF − CapEx | $45.81M | $64.07M | $18.93M | $-5.55M |
Shares Outstanding | 108.09M | 107.77M | 107.75M | 107.64M |